Famous Weight-Loss Drug Claims Life of Egyptian University Student - Sarmad

A popular weight-loss drug has claimed the life of 19-year-old Egyptian student Josephine Nasr while she was in her university accommodation in London.

According to Egyptian media reports, the young woman died after suffering a fatal cardiac arrhythmia, just two hours after taking “Mounjaro,” the brand name for the weight-loss drug tirzepatide, which is marketed in the United States as “Zepbound.”

Details of the shocking incident began to emerge when Josephine experienced a sudden health crisis on campus. She contacted her family—her father George, her mother Lorraine Mansour, and her sister Anastasia—informing them of severe nausea and vomiting. In a state of alarm, her mother promptly contacted a private healthcare service to dispatch a nurse to administer intravenous fluids to her daughter, while her sister attempted to reach university security to check on her.

When university security arrived at the student’s apartment accompanied by the nurse, they knocked repeatedly without receiving a response, prompting them to force entry. They found the girl lying motionless on the bathroom floor. Despite immediately calling emergency services, London Ambulance Service paramedics declared her dead at the scene.

British police found an empty bottle of tirzepatide at the scene. Official investigations revealed that medical tests showed the victim’s body mass index indicated only overweight status, not morbid obesity. It was also established that she had obtained the prescription for the drug from her physician in the United States during the summer of 2025.